Infant With SARS-CoV-2 Infection Causing Severe Lung Disease Treated With Remdesivir.
Pediatrics
; 146(3)2020 09.
Article
em En
| MEDLINE
| ID: mdl-32554811
ABSTRACT
We describe an ex-premature infant presenting with severe acute respiratory syndrome coronavirus 2 infection in the fifth week of life. In current reports, researchers indicate that acute symptomatic severe acute respiratory syndrome coronavirus 2 infection is relatively rare and much less severe than in adults. This case highlights that infection can be associated with life-threatening pulmonary disease in young infants and that infection can follow a similar disease course to that described in adults. We provide first data on the use of the novel antiviral remdesivir in a young child and an innovative approach to expedited approval from a multidisciplinary clinical team and bioethics committee for compassionate access to the drug.
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
11_ODS3_cobertura_universal
Base de dados:
MEDLINE
Assunto principal:
Antivirais
/
Pneumonia Viral
/
Recém-Nascido Prematuro
/
Monofosfato de Adenosina
/
Infecções por Coronavirus
/
Síndrome Respiratória Aguda Grave
/
Alanina
Tipo de estudo:
Diagnostic_studies
Aspecto:
Ethics
Limite:
Female
/
Humans
/
Infant
Idioma:
En
Revista:
Pediatrics
Ano de publicação:
2020
Tipo de documento:
Article